Transcatheter chemical embolization of kidney tumors in somatically complicated patients with advanced renal cell carcinoma as a separate palliative surgery treatment

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
Published: Dec 21, 2015
DOI: https://doi.org/10.30841/2307-5090.4(55).2015.104833
Keywords:
transcatheter chemical embolization, advanced renal cell carcinoma,

##plugins.themes.bootstrap3.article.main##

М. І. Ухаль
Одесский национальный медицинский университет, Ukraine
О. М. Семанів
Одесская областная клиническая больница, Ukraine

Abstract

The efficacy of transcatheter chemical embolization of renal tumors has been investigated in 14 somatically complicated patients with advanced renal cell carcinoma. The effectiveness of treatment has been confirmed that allows stopping the bleeding from the kidney and pain, increase length and quality of life in patients with advanced renal cell carcinoma.

##plugins.themes.bootstrap3.article.details##

How to Cite
Ухаль, М. І., & Семанів, О. М. (2015). Transcatheter chemical embolization of kidney tumors in somatically complicated patients with advanced renal cell carcinoma as a separate palliative surgery treatment. Health of Man, (4(55), 132–133. https://doi.org/10.30841/2307-5090.4(55).2015.104833
Issue
No. 4(55) (2015)
Section
Oncology
Copyright (c) 2020 М. І. Ухаль, О. М. Семанів

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biographies

М. І. Ухаль, Одесский национальный медицинский университет

M.I. Ukhal

О. М. Семанів, Одесская областная клиническая больница

O.M. Semaniv

References

Клиническая онкоурология. Б.П. Матвеева (ред.) (2003), Вердана, Москва, 153 с.

Рак в Україні, 2007–2008. Захворюваність, смертність, показники діяльності онкологічної служби. Бюл. Нац. канцер реєстру України. – Київ, 2009, No 10: 52.

Li M. and Rathmell W.K. The Current Status of Biomarkers for Renal Cell Carcinoma // 2011, P. 153–157.

Zamparese R., Pannone G., Santoro A. et al. Surviving expression in renal cell carcinoma // Cancer Invest. 2008 Nov 1; 26 (9):929–35.

Аляев Ю.Г. Рак почки. Диагностика и лечение // Новый мед. журнал, 1997, No 1. – С. 23–28.

Onishi Т., Oishi Y., Suzuki Y., Asano K. Prognostic evaluation of transcatheter arterial embolization for unresectable renal cell carcinoma with distant metastases // Brit. J. Urol. Int. – 2001. – Vol. 87, N 4. – P. 312–315.

Гранов А.М., Карелин М.И., Таразов П.Г. Рентгеноэндоваскулярная химиожировая эмболизация в лечении почечноклеточного рака: Методические рекомендации МЗ РФ No 96/249, 1997.

Tsuchiya K., Uchida Т., Kobayashi M. / Tumor targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: Longer survival with larger size tumors // Urology. – 2000. – Vol. 55, N 4. – P. 495–500.